CHARLES SCHWAB INVESTMENT MANAGEMENT INC - APREA THERAPEUTICS INC ownership

APREA THERAPEUTICS INC's ticker is APRE and the CUSIP is 03836J102. A total of 66 filers reported holding APREA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of APREA THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$246,000
-29.7%
50,366
-26.5%
0.00%
Q1 2021$350,000
-1.4%
68,561
-4.7%
0.00%
Q4 2020$355,000
-79.2%
71,972
+1.7%
0.00%
-100.0%
Q3 2020$1,703,000
+1.8%
70,748
+64.0%
0.00%0.0%
Q2 2020$1,673,000
+23.6%
43,134
+10.8%
0.00%0.0%
Q1 2020$1,354,000
-23.3%
38,941
+1.2%
0.00%0.0%
Q4 2019$1,766,00038,4720.00%
Other shareholders
APREA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Princeton Global Asset Management LLC 100$4440.00%
Quent Capital, LLC 3$130.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of APREA THERAPEUTICS INC shareholders